GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OptiNose Inc (STU:0OP) » Definitions » Days Payable

OptiNose (STU:0OP) Days Payable : 214.31 (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OptiNose Days Payable?

OptiNose's average Accounts Payable for the three months ended in Mar. 2024 was €2.66 Mil. OptiNose's Cost of Goods Sold for the three months ended in Mar. 2024 was €1.13 Mil. Hence, OptiNose's Days Payable for the three months ended in Mar. 2024 was 214.31.

The historical rank and industry rank for OptiNose's Days Payable or its related term are showing as below:

STU:0OP' s Days Payable Range Over the Past 10 Years
Min: 194   Med: 265.7   Max: 1495.05
Current: 210.55

During the past 9 years, OptiNose's highest Days Payable was 1495.05. The lowest was 194.00. And the median was 265.70.

STU:0OP's Days Payable is ranked better than
83.98% of 974 companies
in the Drug Manufacturers industry
Industry Median: 89.345 vs STU:0OP: 210.55

OptiNose's Days Payable declined from Mar. 2023 (310.10) to Mar. 2024 (214.31). It may suggest that OptiNose accelerated paying its suppliers.


OptiNose Days Payable Historical Data

The historical data trend for OptiNose's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiNose Days Payable Chart

OptiNose Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only 364.54 229.56 261.48 252.24 197.30

OptiNose Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 310.10 227.16 233.57 192.73 214.31

Competitive Comparison of OptiNose's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, OptiNose's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiNose's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OptiNose's Days Payable distribution charts can be found below:

* The bar in red indicates where OptiNose's Days Payable falls into.



OptiNose Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

OptiNose's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (4.995 + 3.563) / 2 ) / 7.916*365
=4.279 / 7.916*365
=197.30

OptiNose's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (3.563 + 1.759) / 2 ) / 1.133*365 / 4
=2.661 / 1.133*365 / 4
=214.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OptiNose Days Payable Related Terms

Thank you for viewing the detailed overview of OptiNose's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiNose (STU:0OP) Business Description

Comparable Companies
Traded in Other Exchanges
Address
1020 Stony Hill Road, Suite 300, Yardley, PA, USA, 19067
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms (mcg), a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.

OptiNose (STU:0OP) Headlines

No Headlines